glp-1 kidney news Frontiers glp-1 kidney outcomes news Agonism

The majority of patients with diabetes develop GI symptoms during the course of their disease, and gastroparesis often goes undiagnosed

Explore our regular blog posts for fresh insights and trends in dermal fillers and toxins

Genetic Testing and Personalized Risk Assessment with PlexusDx The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways

These regions process visceral sensory information and contribute to nausea responsesexplaining why nausea is a common adverse effect when initiating GLP-1 receptor agonist therapy